| Role | Company | Country | Status | Date Range |
|---|---|---|---|---|
| Officer | KYNOS THERAPEUTICS LTD | 🇬🇧Regno Unito | Liquidation | 07/04/2026 – 15/03/2022 |
| Person with significant control | EPIDAREX MANAGEMENT LTD | 🇬🇧Regno Unito | Active | 26/06/2024 – present |
| Officer | EPIDAREX PARTNERS LIMITED | 🇬🇧Regno Unito | Active | 25/03/2026 – present |
| Person with significant control | EPIDAREX CAPITAL MANAGEMENT LLP | 🇬🇧Regno Unito | Proposal to strike off | 26/06/2024 – present |
| Person with significant control | EPIDAREX CAPITAL FP, LLP | 🇬🇧Regno Unito | Active | 15/12/2025 – present |
| Person with significant control | EPIDAREX CAPITAL PARTNERS LIMITED | 🇬🇧Regno Unito | Active | 25/06/2024 – 17/06/2019 |
| Person with significant control | EPIDAREX CAPITAL CP, LLP | 🇬🇧Regno Unito | Active | 15/12/2025 – present |
| Officer | CLYDE BIOSCIENCES LIMITED | 🇬🇧Regno Unito | Active | 12/02/2026 – present |
| Officer | INSPIRING SCOTLAND | 🇬🇧Regno Unito | Active | 19/03/2026 – present |
| Officer | EPIDAREX CAPITAL CP, LLP | 🇬🇧Regno Unito | Active | 08/05/2026 – present |
| Officer | EPIDAREX CAPITAL FP, LLP | 🇬🇧Regno Unito | Active | 12/12/2025 – present |
| Officer | EPIDAREX CAPITAL PARTNERS LIMITED | 🇬🇧Regno Unito | Active | 11/12/2025 – present |
07/04/2026
United Kingdom → United States
19/03/2026
Scotland → United Kingdom
30/11/2012
appointed